TLSA - Tiziana Life Sciences PLC

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Show:
Income Statement
Balance Sheet
Cash Flow
Annual

Income Statement

Currency in GBP. All numbers in thousands
Breakdown
ttm
12/30/2018
12/30/2017
12/30/2016
12/30/2015
Total Revenue
-
0
-
-
-
Cost of Revenue
-
0
-
-
-
Gross Profit
-
0
-
-
-
Operating Expenses
Research Development
3,568
4,132
4,672
2,956
6,287
Selling General and Administrative
-
-
-
-
-
Total Operating Expenses
7,676
7,445
8,246
7,288
8,614
Operating Income or Loss
-7,676
-7,445
-8,246
-7,288
-8,614
Interest Expense
-
9
9
9
18
Total Other Income/Expenses Net
-
-
-
-
-
Income Before Tax
-7,687
-7,454
-8,255
-7,297
-8,632
Income Tax Expense
-
-1,459
-1,485
-89
0
Income from Continuing Operations
-6,126
-5,995
-6,770
-7,208
-8,632
Net Income
-6,127
-5,995
-6,770
-7,208
-8,632
Net Income available to common shareholders
-6,127
-5,995
-6,770
-7,208
-8,632
Reported EPS
Basic
-
-0.47
-0.64
-0.77
-0.95
Diluted
-
-0.47
-0.64
-0.77
-0.95
Weighted average shares outstanding
Basic
-
12,755
10,640
9,359
9,124
Diluted
-
12,755
10,640
9,359
9,124
EBITDA
-
-7,433
-8,235
-7,280
-8,614